Global Rare Biomarkers Specimen Collection & Stabilization Market by Product Type, Collection Type, Application, End Use - Forecast 2024-2030- Product Image

Sale

Global Rare Biomarkers Specimen Collection & Stabilization Market by Product Type, Collection Type, Application, End Use - Forecast 2024-2030

Report
182 Pages
March 2024
Region: Global
360iResearch™
ID: 5674818

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Rare Biomarkers Specimen Collection & Stabilization Market size was estimated at USD 29.94 billion in 2023, USD 32.21 billion in 2024, and is expected to grow at a CAGR of 7.54% to reach USD 49.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rare Biomarkers Specimen Collection & Stabilization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rare Biomarkers Specimen Collection & Stabilization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rare Biomarkers Specimen Collection & Stabilization Market, highlighting leading vendors and their innovative profiles. These include ABL, Inc., ACM Global Laboratories, Almac Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMérieux, Inc., Charles River Laboratories International, Inc., IQVIA Inc., Labcorp Drug Development, NorthEast BioAnalytical Laboratories LLC, PerkinElmer Inc., SGS Société Générale de Surveillance SA, Svar Life Science AB, and Synexa Life Sciences BV.

Market Segmentation & Coverage

This research report categorizes the Rare Biomarkers Specimen Collection & Stabilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
- Circulating Cell Free DNA
- Circulating Tumor Cells
- Exosomes or Extracellular Vesicles
Collection Type
- Blood Collection Tubes & Systems
- Isolation Kits & Reagents
Application
- Cardiovascular Diseases
- NIPT
- Oncology
- Pharmacogenomics
- Population Screening
- Transcriptomics
- Transplant Rejection
End Use
- Hospitals
- Perinatal Clinics
- Physician Labs
- Private or Commercial Labs
- Public Health Labs
- Research Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Rare Biomarkers Specimen Collection & Stabilization Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rare Biomarkers Specimen Collection & Stabilization Market?
What are the technology trends and regulatory frameworks in the Rare Biomarkers Specimen Collection & Stabilization Market?
What is the market share of the leading vendors in the Rare Biomarkers Specimen Collection & Stabilization Market?
Which modes and strategic moves are suitable for entering the Rare Biomarkers Specimen Collection & Stabilization Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Rare Biomarkers Specimen Collection & Stabilization Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising preference of a non-invasive mode of disease treatment
5.1.1.2. Increasing demand for personalized medicine
5.1.1.3. Growth in number of research studies to depict the role of circulating biomarkers
5.1.2. Restraints
5.1.2.1. Stringent regulations in the industry
5.1.3. Opportunities
5.1.3.1. Innovation of novel assays such as liquid biopsy assays
5.1.3.2. Collaborative initiatives for market developments
5.1.4. Challenges
5.1.4.1. Limited reimbursement scenario
5.1.4.2. Complexities in characterization and ineffective separation protocols
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Rare Biomarkers Specimen Collection & Stabilization Market, by Product Type

6.1. Introduction
6.2. Circulating Cell Free DNA
6.3. Circulating Tumor Cells
6.4. Exosomes or Extracellular Vesicles

7. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Type

7.1. Introduction
7.2. Blood Collection Tubes & Systems
7.3. Isolation Kits & Reagents

8. Rare Biomarkers Specimen Collection & Stabilization Market, by Application

8.1. Introduction
8.2. Cardiovascular Diseases
8.3. NIPT
8.4. Oncology
8.5. Pharmacogenomics
8.6. Population Screening
8.7. Transcriptomics
8.8. Transplant Rejection

9. Rare Biomarkers Specimen Collection & Stabilization Market, by End Use

9.1. Introduction
9.2. Hospitals
9.3. Perinatal Clinics
9.4. Physician Labs
9.5. Private or Commercial Labs
9.6. Public Health Labs
9.7. Research Institutes

10. Americas Rare Biomarkers Specimen Collection & Stabilization Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Rare Biomarkers Specimen Collection & Stabilization Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. ABL, Inc.
14.1.2. ACM Global Laboratories
14.1.3. Almac Group
14.1.4. Becton, Dickinson and Company
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. BioAgilytix Labs, LLC
14.1.7. bioMérieux, Inc.
14.1.8. Charles River Laboratories International, Inc.
14.1.9. IQVIA Inc.
14.1.10. Labcorp Drug Development
14.1.11. NorthEast BioAnalytical Laboratories LLC
14.1.12. PerkinElmer Inc.
14.1.13. SGS Société Générale de Surveillance SA
14.1.14. Svar Life Science AB
14.1.15. Synexa Life Sciences BV
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET RESEARCH PROCESS
FIGURE 2. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2023 VS 2030
FIGURE 3. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET DYNAMICS
FIGURE 7. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2030 (%)
FIGURE 10. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 14. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING CELL FREE DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES OR EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 10. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NIPT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 21. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PERINATAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHYSICIAN LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRIVATE OR COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 40. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 62. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 64. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 66. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 135. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 137. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 151. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 153. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 155. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 157. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 195. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 196. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
TABLE 197. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET LICENSE & PRICING

Companies Mentioned

ABL, Inc.
ACM Global Laboratories
Almac Group
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
BioAgilytix Labs, LLC
bioMérieux, Inc.
Charles River Laboratories International, Inc.
IQVIA Inc.
Labcorp Drug Development
NorthEast BioAnalytical Laboratories LLC
PerkinElmer Inc.
SGS Société Générale de Surveillance SA
Svar Life Science AB
Synexa Life Sciences BV

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 32.21 Billion
Forecasted Market Value ( USD ) by 2030	$ 49.83 Billion
Compound Annual Growth Rate	7.5%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Rare Biomarkers Specimen Collection And Stabilization Market Size, Share & Trends Analysis Report By Biomarker, By End-use (Research, Diagnostics), By Region, And Segment Forecasts, 2023 - 2030

Rare Biomarkers Specimen Collection and Stabilization - Global Strategic Business Report

Global Rare Biomarkers Specimen Collection And Stabilization Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

Global Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone Marrow, Blood), Product, Technology, End-use, Region, and Segment Forecasts, 2024-2030

Circulating Tumor Cells Global Market Report 2024